VRTX — VERTEX PHARMACEUTICALS INC

Ownership history in XTX Topco Ltd · 13 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in VERTEX PHARMACEUTICALS INC (VRTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.42% (2023 Q3)

Avg. % of fund

0.2%

First filed

2021 Q4

Last filed

2025 Q3

Quarters held

13

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	ADDED	9,690	+5,165	+114.1%	0.20%	$3.8M	$391.64
2025 Q2	ADDED	4,525	+1,995	+78.9%	0.08%	$2.0M	$445.20
2024 Q4	REDUCED	2,530	-5,919	-70.1%	0.08%	$1.0M	$402.70
2024 Q2	ADDED	8,449	+5,731	+210.9%	0.34%	$4.0M	$468.72

% of Fund (quarterly) VRTX price (monthly, adj. close)

Other funds also holding VRTX

As of 2025 Q4 — sorted by position size

Provident Investment Management, Inc. 3Y 7Y 6.16% Bellevue Group AG 3Y 7Y 5.85% Andrew Hill Investment Advisors, Inc. 3Y 4.28% Iron Triangle Partners LP 3Y 3.99% Atle Fund Management AB 3Y 7Y 3.32% MCRAE CAPITAL MANAGEMENT INC 3Y 7Y 3.29% Sofinnova Investments, Inc. 3Y 7Y 3.22% SECTORAL ASSET MANAGEMENT INC 3Y 7Y 2.91% Birch Hill Investment Advisors LLC 3Y 7Y 2.89% NIA IMPACT ADVISORS, LLC 3Y 2.68%

← Back to XTX Topco Ltd Holdings